Real World Evidence
(RWE) Studies

Accelerate multi-center Real World Evidence (RWE) studies while ensuring privacy, confidentiality and regulatory compliance.

Real World Evidence
(RWE) Studies

Accelerate multi-center Real World Evidence (RWE)
studies while ensuring privacy, confidentiality and
regulatory compliance.

Collaborate on Real World Data Analysis without Compromising Patient Privacy

Real World Evidence (RWE) studies are the engine of medical and pharmaceutical innovation – but concerns around data privacy, security, regulation, and confidentiality make collaborative medical data analysis cumbersome.

Duality SecurePlus enables organizations to accelerate multi-center RWE studies by protecting the data during all phases of collaboration — even during its analysis — keeping privacy, confidentiality, and regulatory compliance intact. By leveraging Homomorphic Encryption, stakeholders can securely combine and analyze sensitive data, such as linking patient health records, validating data correctness, performing statistical analysis, fitting regression models, and applying survival analysis without ever decrypting. All data owners remain in control of how their data is used during the collaboration process.

Medical Centers,
HMOs

Full control over data sets

Get answers to questions on accounts,
entities, and transactions in seconds.

Increase the value of your data

Prevent fraud losses and improve
the quality of regulatory reporting.

Drive growth and monetization data

through secure and compliant
participation in RWE studies.

Pharmaceutical Companies,
Research Centers

Accelerate RWE studies

by removing data privacy and data
ownership concerns.

Eliminate re-identification risks

by keeping the data encrypted
during analysis.

Obtain accurate RWE results

by analyzing real data while it’s encrypted
- i.e., data otherwise inaccessible using
traditional

Obtain accurate RWE results

by analyzing real data while it’s encrypted - i.e., data otherwise inaccessible using traditional

“In healthcare research, it is imperative to collaborate on data to derive robust conclusions about the effectiveness of treatments. Duality’s SecurePlus solution facilitates privacy-preserving data sharing for the benefit of patients and the entire healthcare community.“

Dr. Ravit Geva |
Head, GIT malignancies Center Head, Research & Innovation Unit,
Deputy Director Division of Oncology, Tel Aviv Sourasky Medical Center
Experience Real World Evidence (RWE) Studies

Maximize the value of sensitive, regulated, or confidential data.

Experience Real World Evidence (RWE) Studies

Maximize the value of sensitive, regulated, or confidential data.

Duality Secures $30M Round of Series B Funding >> Read More